CME Accreditation for the 15th ICID
2011.12.01 CME Accreditation Notice:

The 15th International Congress on Infectious Diseases is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS),

The 15th International Congress on Infectious Diseases is designated for up to 18 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.


Specific Learning Objectives

Physicians, scientists and microbiologists who attend the 15th ICID will be able to articulate an updated knowledge of developments on the diagnosis, prevention, treatment or control of infectious diseases around the world. Since the Society recognizes that communities differ in resources available for health care and research, and that there are valuable lessons to be learned by sharing experiences from different backgrounds, attendees will understand new approaches in different aspects of basic science research, new developments diagnostics for infectious diseases in both developed and developing settings, and strategies for the treatment of a variety of infectious diseases under different resource constraints. A further objective of the Congress is to provide physicians, scientists and public health officials an opportunity to learn from their colleagues various strategies to approach important infectious disease problems.

Specifically, all participants will likely attend the 15th ICID plenary lectures and at the close of the Congress will:

  • Be versed in the latest global efforts on malaria eradication;
  • Understand the history of the discovery of HIV and comprehend how the prevention of transmission of HIV will likely unfold by looking at trends and other clues from the early 21st century;
  • Understand the effect of international health and global migration on emerging infections, tropical diseases, and vaccine-preventable diseases in various mobile populations including travelers;
  • Appreciate the impact on adults of Pneumococcal infections in children;
  • Be aware of the microbial ecology of infectious diseases.

By choosing from an array of presentations in a series of parallel sessions, participants at the 15th ICID will be able to:

  • Plan a rational approach for the treatment and prevention of neonatal sepsis;
  • Articulate the latest updates on prevention and care of bacterial Meningitis;
  • Understand the burden of Plasmodium vivax malaria in Latin America and approaches to treating the disease;
  • Recognize the threat of antibiotic 'Panresistance' posed by Carbapenemase-producing bacteria and understand ways to prevent and manage this problem;
  • Know the particulars of the current challenges in HIV care;
  • Understand international perspectives on infection control;
  • Understand the promise and limitations of short course antibiotic treatment of childhood Pneumonia ;
  • Comprehend the latest information on current topics related to fungal infections;
  • Understand the disease mechanism and control of MRSA infections;
  • Appreciate current issues in the emergence and handling of multi drug resistant gram-negative infections
  • Recognize the utility of biomarkers in the diagnosis and management of infectious diseases
  • Understand the application of antimicrobial stewardship in the prevention of antibiotic resistance;
  • Understand the latest information about new tools available for the management of tuberculosis around the world;
  • Understand the promise of specific approaches to the elimination of AIDS.